EMA Recommends Granting a Marketing Authorisation for Generic Trabectedin By Ogkologos - April 30, 2025 469 0 Facebook Twitter Google+ Pinterest WhatsApp Trabectedin Accord is a generic of Yondelis, which has been authorised in the EU since 2007 Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Qué saber sobre los diferentes tipos de mastectomías para el cáncer... November 15, 2023 Multipronged Approach Eliminates Racial Disparities in Early-Stage Lung Cancer Treatment March 5, 2019 Risk of Anal Cancer Significantly Lower with Treatment for Anal High-Grade... June 22, 2022 Woman Showed Up To Their Wedding And Stole All Their Gifts.... March 11, 2019 Load more HOT NEWS Study Shows CAR T-Cell Therapy Is Effective at Putting Childhood Leukemia... How My Navy Career Helped Shape My Positive Attitude During My... ΚΑΡΚΙΝΟΣ ΟΡΧΕΩΝ Professor Eithne Costello: On the road to early detection
